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Koichi Akashi*† and Irving L Weissman* constitutive expression of an lck transgene (Mombaerts
et al., 1994), or treatment with g irradiation (Guidos et*Departments of Pathology and Developmental Biology
al., 1995) can also lead to the appearance of DP thymo-Stanford University School of Medicine
cytes in RAG1 knockoutmice. Therefore, it is reasonableStanford, California 94305
to assume that TCRlo DP thymocytes in normal mice†First Department of Internal Medicine
should contain a considerable number of cells that willFaculty of Medicine
fail toexpress TCRab molecules that can be restricted toKyushu University
self-MHC, and these are mainly destined for intrathymicFukuoka
death (the default pathway) (Guidos et al., 1990).Japan
We demonstrated that the DP cells capable of differ-
entiating into CD41CD82 or CD42CD81 single-positive
(SP) cells were mainly contained in the blast fraction ofSummary
TCRlo CD41CD81 thymocytes, whereas most, if not all
so-called small DP thymocytes were destined to defaultPositive selection of T cells begins with TCRablo thy-
death (Guidos et al., 1990). Presumably, these smallmic progenitors. Here, we show that the most efficient
thymocytes are derived from DP blast thymocytes as aTCRlo progenitors are c-kit1 with intermediate levels
result of neglect (Surh and Sprent, 1994). The results ofof CD4 and CD8 (DPint). Positive selection of DPint TCRlo
positive selection includes populations of TCRmedc-kit1 cells results in TCRmed CD691 c-kit1 transitional
CD41CD8lo or CD4loCD81 transitional intermediates (TIs),intermediates that show increased TCRVb frequen-
which committed to the CD4 and CD8 lineages, respec-cies to selecting superantigen (SAg) that are commit-
tively (Guidos et al., 1990). However, several reportsted to the CD4 or CD8 pathway. The cells on the c-kit1
showed that small DP thymocytes also retain the capac-maturation pathway maintain Bcl-2 expression. Most
ity to undergo positive selection to SP cells (LundbergDPint c-kit1 progenitors fail positive selection, and be-
and Shortman, 1994; Swat et al., 1994).come DPhi c-kit2 cells that lose Bcl-2 expression. Some
Recent studies have revealed the presence of bothDPhi c-kit2 blast cells can be salvaged to produce ma-
TCRhi CD4medCD81 and TCRhi CD41CD8med TI thymocytesture single-positive (SP) cells. DPint c-kit1 maturation
in both MHC class I knockout mice and MHC class IIto SP cells can occur in <12 hr in vitro on thymic
knockout mice. These cells are medium-sized cells thatstromal monolayers.
express CD69, suggesting that these coreceptor-
skewed (CRS) thymocytes could represent a transitional
Introduction differentiation step from DP cells to mature SP cells
(Chan et al., 1993; Crump et al., 1993). These findings
The thymus is the major site of differentiation of T lym- were interpreted to mean that these CRS cells were
phocytes. During thymic maturation, thymic progenitors generated from DP cells due to stochastic down-regula-
acquire various cell surface molecules, including CD4, tion of either coreceptor (Chan et al., 1993; Crump et
CD8, and the T cell receptors (TCRs) associated with al., 1993; van Meerwijk and Germain, 1993; van Meerwijk
the invariant CD3 polypeptides, all under the influence et al., 1995), rather than instructive down-regulation of
of the thymic microenvironment (Adkins et al., 1987; one coreceptor. Lucas et al. (1995, 1996) showed evi-
Weissman, 1994). Successive and successful re- dence that TCRmed CD4medCD81 thymocytes do not be-
arrangement of TCR b and a chains results in the emer- long to the CD8 lineage pathway, but represent a MHC
gence of CD41CD81 (double-positive [DP]) progenitors class II–restricted deadend subset. This suggests com-
that express low levels of TCRab. At least some of these mitment to the CD8 lineage may be instructive (Lucas
TCRlo DP thymocytes are subjected to a stringent selec- et al., 1996). On the other hand, TCRmed CD41CD8med cells
tion process, including positive selection for appropriate (Lundberg et al., 1995) or TCRmed CD4med–hiCD8med cells
interaction with the self-major histocompatibility com- (Suzuki et al., 1995) in normal and MHC class II knockout
plex (MHC) proteins of the antigen-presenting system mice have been reported to possess the capability of
(for review see Fowlkes and Schweighoffer, 1995; von differentiation into CD8 SP cells as well as CD4 SP cells.
Boehmer, 1994), and negative selection against reactiv- These authors postulate that CD4 lineage commitment
ity with a variety of self-antigens and superantigens occurs regularly, whereas the CD8 lineage commitment
(SAg), in the context of self-MHC (Kappler et al., 1987; requires an instructive signal by MHC class I–TCR inter-
Marrack et al., 1988; Nossal, 1994). Only 1%–4% of thy- action. These are distinct commitment models, each
mocytes survive selection and progress to become ma- supported by consistent experiments (reviewed by von
tureT cells (the maturation pathway) that emigrate to the Boehmer, 1996).
periphery (Weissman, 1967, 1973; Scollay et al., 1980). The early stage of thymic maturation may also involve
The events that result in double-negative (DN) cells expression of surface c-kit and cytoplasmic Bcl-2: c-kit
becoming DP cells can be studied in unmodified or in is expressed in thymic subsets, and the interaction with
gene-targeted/transduced mice; The treatment of RAG1 steel factor (Slf) has been reported to be involved in
(or TCRb)-deficient mice with anti-CD3e antibody in- early thymocyte proliferation (Suda and Zlotnik, 1991;
duces appearance, expansion, or both, of DP thymo- Godfrey et al., 1992; Sudo et al., 1993; Matsuzaki et al.,
1993; Peschon et al., 1994; Rodewalt et al., 1995). c-kit1cytes (Levelt et al., 1993; Shinkai and Alt, 1994) and
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Figure 1. Thymocyte Subsets Obtained by Counterflow Centrifugal Elutriation
Thymocytes were subdivided into four fractions, 16–20 ml/min, 21–24 ml/min, 25–28ml/min, and rotor-off populations, and stained with CD4,
CD8, c-kit, and PI. Top, shows CD4 and CD8 profiles. Bottom, depicts the c-kit distribution of these fractions. Small windows in the bottom
panels are forward light angle scatter (FLS) profiles for each population.
CD32CD42CD82 or more primitive CD32CD4loCD82 thy- c-kit1 CD41CD8med or CD4medCD81 TIs, which are under-
going positive selection to the CD4 and the CD8 lineage,mocytes can repopulate the irradiated adult thymus
(Godfrey et al., 1992), and the proliferation of c-kit1 respectively, without passing through DPhi cells. Thymo-
cytes on this pathway retain Bcl-2 expression, while theCD32CD42CD82 thymocytes in the presence of Slf and
interleukin-7 (IL-7) was blocked by a neutralizing anti- majority of the DPhi large and small cells are Bcl-22 and
in this view are mainly on the default pathway. This novelc-kit antibody (at high concentration) (Godfrey et al.,
1992). Bcl-2, an anti-apoptosis protein (Hockenbery et c-kit1 maturation pathway is estimated to contribute at
least a half of thymic T cell maturation.al., 1991; Vaux et al., 1992), has also been reported to
play a role in cell survival during thymic differentiation
(Gratiot-Deans et al., 1993; Moore et al., 1994). Both Results
c-kit and Bcl-2 are reportedly down-regulated at the
DP stage. This down-regulation of both molecules may c-kit Expression in Thymocytes Reveals
New Subpopulationsmake thymocytes at the DP stage sensitive to apoptotic
signals during the selection process based on their TCR We subfractionated thymocytes into four different CCE
fractions. The top panels in Figure 1 show the CD4 andstructure.
The object of this study was to define more precisely CD8 profiles for each CCE fraction. The small cells ob-
tained in the flow rate fraction of 16–20 ml/min wereprogenitors and progeny in the maturation and default
pathways, beginning with DP blast progenitors. We first mostly CD41CD81 thymocytes. Most of the CD41CD82
or CD42CD81 SP thymocytes, and CD41CD8lo–med orfractionated thymocytes by counterflow centrifugal elu-
triation (CCE) to separate large numbers of thymocytes CD4lo–medCD81 transitional thymocytes appeared in the
small tomedium-sized thymocyte population (21–24andby size. We found that the majority of c-kit1 cells were
contained in the DPint blast population, while most DPhi 25–28 ml/min, respectively). In the rotor-off population
(around 10% of total thymocytes), namely blast thymo-blasts did not express c-kit. We present evidence that
the DPint c-kit1 (TCRlo) population contains mainly pro- cytes, most SP thymocytes and CD41CD8lo–med tran-
sitional thymocytes were depleted. The majority ofgenitors that have not received TCR/SAg-mediated pos-
itive selection. This population directly produces TCRmed the blast population consisted of a continuum from
Table 1. Percentages of c-kit Cells and Cycling Cells in Each Elutriator Fraction
Flow rate Total percent Percent c-kit2 of fraction Percent c-kitlo of fraction Percent c-kithi of fraction Percent
(ml/min) of cells (of total) (of total) (of total) cycling cells
16–20 9.5 99.97 (9.50) 0.02 (,0.01) ,0.01 (,0.01) 0
21–24 60.4 99.66 (60.19) 0.30 (0.18) 0.04 (0.02) 0.8
25–28 17.8 98.28 (17.49) 1.45 (0.26) 0.27 (0.05) 3.1
Rotor-off 12.2 91.04 (11.11) 6.22 (0.76) 2.74 (0.34) 33.2
Total thymocytes were subfractionated according to different flow rates (ml/min) on elutriation. Parenthesis indicate estimated percentages
of c-kit1 cells in total thymocytes. The definition of c-kit lo and c-kithi cells (versus c-kit2) is shown in Figure 1. Cycling cells represent cells in
S/G2/M phases of cell cycle by PI staining as described in Experimental Procedures. Results are shown in mean values of three independent
experiments.
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Figure 2. The CD4 and CD8 Profiles of c-kit1 Cells in Unfractionated and Blast Thymocytes
Freshly isolated total thymocytes (A–C) and the rotor-off elutriator fraction (blast thymocytes) (D–F) were stained and analyzed by the same
experimental procedure as in Figure 1. The numbers in gating squares in (D) to (F) represent the DN (1), DPlo (2), DPint (3), and DPhi (4)
subpopulations. Bottom, shows the CD3/c-kit profiles of each subpopulation of greater than or equal to medium-sized (25 ml/min of elutriator
fraction) thymocytes. The c-kithi cells are recognized as a distinct population in the DPint stage. The DPint population contains TCRmed c-kit2
population (see Discussion).
CD42CD82 to CD41CD81 thymocytes. c-kit1 cells were medCD81 transitional thymocytes. The distribution of
c-kit1 cells from DN to DPint stages was skewed towardhighly enriched (up to 9%) in the blast population, and
CD8 (Figure 2); the c-kit1 population probably includeswere virtually absent from the small cell–enriched CCE
the CD81 (CD4lo) progenitor (Crispe et al., 1987; Guidos(16–24 ml/min) fractions that include around 70% of all
et al., 1989). The bottom panels show CD3/c-kit profilesthymocytes (Table 1). The c-kit1 cells can be arbitrarily
of greater than or equal to medium-sized thymic sub-divided into c-kitlo and c-kithi subsets (Figure 1). Cycling
populations (>24 ml/min of CCE fraction). DPhi cells werecells were mostly seen in blast thymocyte populations,
virtually negative for c-kit and TCRlo; only <0.1% of DPhiindicating that the blast populations are primarily re-
cells (z0.04% of unfractionated DPhi cells) were positivesponsible for expanding thymocyte populations (Table
for c-kit. If c-kit expression does not fluctuate during1). B cells, monocytes, and granulocytes appeared as
thymic maturation, it is reasonable to propose that ata minority of cells (<0.05%) in the 21–28 ml/min CCE
least some fraction of CD41CD8lo–med or CD4lo–medCD81fractions. These cells were c-kit2 (data not shown).
transitional thymocytes might directly differentiate fromFigure 2 shows the distribution of c-kit1 cells in the
the DPint c-kit1 subset of DP thymocytes, and not fromwhole and the blast thymocyte populations. To evaluate
the more numerous DPhi (c-kit2) thymocytes.the c-kit distribution precisely, we divided CD41CD81
thymocytes into DP low (DPlo), DP intermediate (DPint),
and DP high (DPhi) subpopulations (Figure 2D). In most Thymic Subsets Defined by c-kit and CD3
Figure 3 shows the CD4 and CD8 profiles of greaterprevious reports, DN thymocytes were included in the
fractions here called DN plus DPlo thymocytes, while than or equal to medium-sized thymic subpopulations,
defined by CD3–TCR and c-kit expression. The majorityCD41CD81 (DP) thymocytes were in the DPint plus DPhi
fractions. of cells reside in the c-kit2 pool, shown here to be mainly
in area 7. The c-kit2 pool contains DPlo–int c-kit2 and someIn unfractionated thymocytes, c-kit1 cells were seen
in several CD4- and CD8-defined subpopulations, in- TIs, as well as the major population, which is DPhi (c-
kit2) cells. A minority of the greater than or equal tocluding DN, DPlo, DPint, and CD41CD8lo–med and CD4lo–
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Figure 3. CD4 and CD8 Profiles of Thymocytes Defined by CD3 and c-kit Expression
The medium to large-sized cells ($21 ml/min of elutriator fraction) were stained with four-color staining of CD3, CD4, CD8, and c-kit, and
data of 3 3 105 cells were collected. Center, shows CD3/c-kit profiles of this fraction. The dots around the outline of the probability (5%) plot
are the data of single cells. Each number indicated at the side of squares corresponds to those in panels indicated by arrows showing CD4
and CD8 profiles of each population. Note that it is possible that there is thymic development from DN to SP cells by tracking areas 1–6.
medium-sized cells were c-kit1, shown here as areas thymic stroma cell (HTSC) culture system. Sen-Majum-
1–5. In the c-kit1 subsets, the level of CD3–TCR expres- dar et al. (1992) reported that a significant fraction of
sion was correlated with that of CD4 and CD8 expres- CD32CD42CD82 thymocytes differentiated respectively
sion. The TCR2/lo c-kitlo cells contained DN and DPlo cells to CD41CD81 cells and CD3hi SP subsets after 2-day
(area 1). The TCRlo c-kithi cells (area 2) were mostly DPint culture on HTSC.
cells, and some CD4medCD8hi cells. The levels of c-kit Figures 4 and 5 show results of short-term culture of
were inversely correlated with the levels of CD3–TCR several thymocyte subsets on HTSCs. Each population
in the DPint to (TCRmed c-kithi) TIs (CD41CD8med or was sorted by using three-color (CD4, CD8, c-kit) FACS.
CD4medCD81) in areas 3 and 4, and even more so in TCRhi To eliminate contamination of the DP subsets with co-
c-kitlo (CD41CD8lo or CD4loCD81) cells inarea 5. The TCRhi sorted TIs and SP cells, we had to subject the cells to
c-kit2 cells in area 6 were mostly SP cells, containing a second round of FACS sorting (Figure 5). When the
some TI cells. This method of displaying thymic subsets resorted thymocytes were placed on syngeneic HTSCs,
could be interpreted to suggest that cells in the matura- they immediately attached to the stromal layer.
tion pathway pass from areas 1–6. We then directly As shown in Figure 4, a fraction of the DPint c-kithi blast
tested that maturation sequence by lineage outcome population differentiated into TIs as well as SP cells
from purified subsets. within 12–16 hr on HTSCs. These differentiation steps
were almost completed within 12 hr, since their profiles
after 36 hr culture were quite similar to those after 12The Differentiation Capacity of DPint c-kithi
hr culture (data not shown). The SP cells that had differ-Cells In Vitro (on Heterogeneous Thymic
entiated from DPint c-kithi thymocytes expressed highStroma Cell Cultures)
levels of CD3, but lost HSA expression, and by forwardTo evaluate the differentiation potential of DPint c-kithi
(TCRlo) blasts in vitro, we employed the heterogeneous light angle scatter (FLS) were, like SP CD31 cells in
c-kit1 Thymic Maturation Pathway
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Figure 4. Rapid Differentiation of DPint c-kithi Blast Thymocytes on HTSCs
(A) The differentiation of DPint c-kithi and DPint c-kit2 blast thymocytes after 16 hr culture on HTSCs. DPint c-kithi blasts differentiated into SPs
within 16 hr on HTSCs, while the DPint c-kit2 population did not show significant differentiation potential in the same condition.
(B) The differentiation of DPint c-kithi thymocytes after 12 hr in several conditions such as on HTSCs, on HTSCs plus treatment with anti-Slf
and anti-c-kit neutralizing antibodies, in medium only (without HTSCs), and in medium plus Slf.
situ, medium-sized cells, indicating that they had fully could be regarded as dying (shrinking) or apoptotic cells.
DPhi progeny were CD3lo and slightly larger than SP cellsmatured (data not shown). In addition to SP cells, DPint
c-kithi thymocytes produced large numbers of DPhi and after 12 hr culture, but became small after 36 hr culture,
suggesting that they were also not on the maturationalso some DN (DPlo) cells (see Figure 4). The FLS profiles
of these cell populations revealed that the DN progeny pathway in vitro (data not shown).
In contrast, DPint c-kit2 blasts mainly differentiated intowere very small cells, suggesting that most of them
Figure 5. Results of In Vitro Culture of DPhi
thymocytes on HTSCs
(A) The CD4/CD8 profile of the sorted DPhi
cells from <25 ml/min CCE fraction for exam-
ple. Although the DPhi population was ob-
tained by CD4 and CD8, and strict FSC gates
shows more than 99% of purity, considerable
numbers of TIs and SP cells contaminate
probably by doublets,coincidental sorting, or
both, of wrong droplets containing TIs and
SP cells. The resorted population contains
virtually no TIs and SP cells.
(B) Results of culture of resorted DPhi cells
from each CCE fraction on HTSCs after 16 hr.
Immunity
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Figure 6. Differentiation Capacity of c-kit1 CD4hiCD8med and CD4medCD8hi Transitional Intermediates
The squares in the left (A and B) represent gates for sorting TIs, and CD4 and CD8 profiles of sorted c-kithi CD41CD8med and CD4medCD81 cells,
respectively. The right panels show the differentiation of each sorted c-kithi TIs after 16 hr culture on HTSCs. In these experiments, recovery
rates were z20%.
DPhi cells within 16 hr (see Figure 4A). Only a small TIs, and tested their differentiation capacity on HTSCs
fraction of them might have differentiated into SP cells in vitro. As shown in Figure 6, the c-kit1 CD41CD8med
on HTSCs (<1%). These results obtain even after 36 hr population almost exclusively differentiated into
cultivation (data not shown). CD41 CD82 SP thymocytes after 16 hr culture. The c-kit1
The differentiation of DPint c-kithi thymocytes along the CD4medCD81 population gave rise to large numbers of
maturation pathway was completely dependent on the CD42CD81 SP cells, and fewer but significant numbers
HTSC: in the absence of the stromal layer, they up- of CD41CD82 SP cells also. Very likely, both the CD81
regulate both CD4 and CD8, and become DPhi cells, but progenitors (Crispe et al., 1987; Guidos et al., 1989), as
could not differentiate to SP cells when cultured with well as the CD4medCD81 TIs, were included in this sorted
the medium (see Figure 4B). On the other hand, the population. Both transitional intermediate populations
differentiation of DPint c-kit2 cells to DPhi cells occurred (CD41CD8med and CD4medCD81) also produced some DPhi
after 12 hr culture with medium alone (data not shown). and DN progeny in addition to SP cells. The DN progeny
The addition of recombinant Slf to the medium did not were again small cells (data not shown), as was the case
promote their differentiation (see Figure 4B). Preincuba- with the culture of DPint c-kithi thymocytes. These results
tion with neutralizing anti-c-kit and anti-Slf antibodies indicate that c-kit1 CD41CD8med or CD4medCD81 transi-
with the DPint c-kithi thymocytes and the stromal layer, tional blasts contain a major subpopulation that have
respectively, did not inhibit their differentiation (see Fig- committed to either the CD4 or the CD8 lineage.
ure 4B). Thus, triggering c-kit in these cells is neither
necessary nor sufficient for their passage along the mat-
The Differentiation Capacity of DPint c-kithiuration pathway, at least in vitro.
Cells In Vivo (on Intrathymic Injection)DPhi cells from each CCE fraction show only a very
We evaluated the differentiation potential of DPint c-kithiminor differentiation capacity into SP cells (<0.5%) (Fig-
thymocytes from C57BL/6/Ka Thy1.1 (Ly5.1; Thy1.1)ure 5), even after 36 hr culture on HTSCs (data not
mice in vivo by using intrathymic injection (i.t.) into unir-shown). The recovery rates of DPhi populations 16 hr
radiated congenic C57BL/6. Ly5.2 (Ly5.2; Thy1.2) mice.afterculture on HTSC were significantly lower than those
As shown in Figure 7, the DPint c-kithi blasts gave rise toof DPint c-kithi cells, which were 20%–30% (see Figure
progeny that include DPlo, DPint, DPhi, and the two TI4): the recovery rates of DPhi cells were highest (3.2%)
classes, but not SP cells 3 days after injection. At 4 daysstarting with the DPhi blasts (rotor-off fraction), and low-
postinjection, they had differentiated in addition intoest (1.4%) starting with the small DPhi (<20 ml/min) frac-
either CD41CD82 or CD42CD81 SP thymocytes. Thesetion, supporting previous findings that most of the DPhi
results mirror those reported when all DP blasts wereblast cells gradually decrease their size, and become
injected i.t. (Guidos et al., 1990).small-sized dying DPhi cells (Guidos et al. 1990). Small
Next, we injected DPhi c-kit2 populations from eachDPhi cells produced small DPint cells by down-regulating
CCE fraction in vivo. We could detect donor-derivedCD4 and CD8, probably associated with the dying pro-
cells from the DPhi c-kit2 blast population, but not fromcess (Kishimoto et al., 1995).
small and medium-sized populations, as reported pre-
viously (Guidos et al. 1990). As shown in Figure 7 (right),The Differentiation Capacity of c-kit1
the DPhi c-kit2 blasts almost exclusively give rise to DPhiTransitional Intermediates In Vitro
small thymocytes. By day 4, a small number of SP cellsThe TI subsets can be derived from DPint c-kit1 progeni-
tors on HTSCs (see Figure 4). We therefore sorted c-kit1 appeared; on a per cell injected basis, the frequency of
c-kit1 Thymic Maturation Pathway
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et al., 1994). As shown in Figure 8, TCR2/lo c-kitlo cells
and TCRlo c-kithi cells were mostly negative for CD69.
Dramatic increases of CD69 expression were seen from
TCRmed c-kithi (areas 3 and 4) to TCRhi c-kitlo (area 5)
stages. TCRhi SP cells included cells that had begun to
down-regulate CD69. This is consistent with the hypoth-
esis that positive or negative selection, or both, takes
place during the transition from TCRlo c-kithi to TCRhi
c-kitlo cells.
Forward scatter profiles of these populations indicate
that the TCRlo c-kithi and TCRmed c-kithi cells (areas 3 and
4) are blast cells in cell cycle (Figure 9). TCRhi c-kitlo cells
in area 5 are mainly medium sized, but still contain a
significant fraction of cycling cells (z5%) (Figure 9).
TCRhi c-kit2 cells are smaller and have almost ceased
cell division.
Thymocytes on the c-kit1 Maturation
Pathway Maintain Expression of Bcl-2
Figure 10 shows the expression of Bcl-2 in various sub-
populations of thymocytes. The expression of Bcl-2 is
high in cells on the c-kit1 maturation pathway. On theFigure 7. Differentiation of DPint c-kithi and DPhi (c-kit2) Thymocytes
other hand, DPlo–int c-kit2 (and most DPhi blasts) have lowIn Vivo
levels of Bcl-2 protein, and DP small cells, which in ourThe donor-derived cells were analyzed on 3 and 4 days after in vivo
hands are destined to die (Guidos et al., 1990; Kraft etinjection. CD4 and CD8 profiles of donor-derived cells revealed that
the differentiation from DPint c-kithi cells to SP cells takes z4 days al., 1993), did not express measurable levels of Bcl-2.
in vivo. On the other hand, DPhi cells showed a small differentiation Based on these data, thymocyte precursors on the c-kit1
capacity compared with DPint c-kithi cells (see text). maturation pathway continue to express Bcl-2 during
their maturation process.
their progeny was around 60-fold lower than that of DPint Positive Selection to SAg on the c-kit1
c-kit1 cells (Table 2). Owing to the large number of the Maturation Pathway
DPhi c-kit2 blast population (z10% of total thymocytes), Next, we wished to examine genetic and functional evi-
this population, which is z50-fold larger than the num- dence to test whether this DPint c-kithi population results
ber of DPint c-kit1 cells (z0.2% of total), could be the from or is poised to enter positive selection. A hierarchy
source of up to half of thymic SP mature cells. Interest- of positive selection efficiency for T cells bearing Vb17a
ingly, the DPhi c-kit2 blasts mainly differentiated into CD4 TCRs to endogenous SAg has been demonstrated
SP cells (Table 2). amongst I-E2 haplotypes: H-2q > H-2s > H-2b for the
The progeny of these DPhi c-kit2 blasts included some CD4 lineage, whereas H-2s > H-2q for the CD8 lineage
DPint cells on day 3 and day 4, and so the differentiation (Blackman et al., 1989; Kappler et al., 1989; Zuniga-
to DPint cells could precede appearance of the CD4 or Pflucker et al., 1989). We therefore compared Vb17a
CD8 SP cells. The differentiating DPint subsets did not frequencies among thymocyte subpopulations defined
up-regulate c-kit on day 3 and day 4 (data not shown), by TCR and c-kit in these H-2 haplotypes. First, the Vb17
indicating that these cells never ree¨nter the c-kit1 matu- frequency did not differ at the TCRlo c-kithi stage (see
ration pathway during differentiation to SP cells. Figures 3 and 8, area 2) among these strains, indicating
that this stage precedes positive selection to SAg (Table
3). Among TCRmed c-kithi cells committed to the CD4
The Transition of DPint c-kithi Cells to TI and lineage (the CD41CD8med TIs) in I-E2 haplotypes, the
SP Cells Results from Positive Selection Vb17a frequency is highest in H-2q mice and lowest in
and Involves Cell Proliferation H-2b mice, whereas in those committed to the CD8 lin-
We tested the expression of the very early activation eage (the CD4medCD81 TIs), the Vb17a frequency is
antigen, CD69, which is reportedly induced by TCR liga- higher in H-2s mice than in H-2q mice. The differences
in the Vb17a frequency between these H-2 haplotypestion (Yamashita et al., 1993; Swat et al., 1993; Brandle
Table 2. Production of Progeny 4 Days after Intrathymic Injection
Percent of progeny Numbers of progeny detected per 105 cells transferred
Population Recovery
transferred rate (%) DP CD41 SP CD81 SP CD41 SP progeny CD81 SP progeny CD41 SP plus CD81 SP
DPint c-kit1 1.8 6 0.6 21.3 6 8.9 6.4 6 3.6 3.3 6 1.2 115 6 61 59 6 22 174 6 78
DPhi c-kit2 0.09 6 0.02 96.6 6 1.2 3.2 6 0.5 0.4 6 0.1 2.9 6 0.4 0.3 6 0.1 3.3 6 0.4
Data were shown as mean 6 SD in three experiments.
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Figure 8. CD69 Expression in Thymocyte
Subsets Defined by CD3 and c-kit
CD69 expression of each thymocyte subset
was evaluated by using the same thymocyte
population used in Figure 3. Each number
indicated at the side of squares corresponds
to those in panels showing CD69 profiles of
each population. The CD3lo c-kitlo–hi (areas 1
and 2) populations are mostly negative for
CD69, whereas the increase of CD69 expres-
sion can be seen in CD3med–hi c-kit1 popula-
tions (areas 3–5).
continue to increase as they mature into TCRhi c-kit2 and Bcl-2 as a result of positive selection, presumably
signaled through their TCRs. Thymic T cells whose TCRs(CD41CD82 or CD42CD81) cells. Thus, the Vb17a fre-
quency at the TCRmed c-kit1 transitional stage reflects are inappropriate for recognition of their own thymic
environment, presumably represented by thymic stro-the previously described efficiency of positive selection
for each strain. Based on these data, positive selection mal cells, cease expression of c-kit and Bcl-2. (the de-
fault pathway). We speculate that the loss of Bcl-2 per-takes place at the TCRmed c-kit1 TIs, and the TCRlo c-kithi
cells have not received positive selection. mits the diurnal cycle of glucocorticoid expression to
induce the intracellular signals leading to apoptosis
(Weissman and Levy, 1975), because the cells on theDiscussion
c-kit1 pathway are glucocorticoid resistant (unpublished
data).In this paper, we demonstrate the existence of c-kit1
(Bcl-21) maturation pathway of thymic T cells. This matu- The c-kit1 maturation pathway does not include DPhi
cells, which are more commonly regarded as the TCRloration pathway, with high efficiency, extends at least
from DPint c-kithi TCRlo to SP mature cells. We propose progenitors. Because the major DP population having
T cell progenitor activity in normal mice actively residedthat developing thymic cells continue to express c-kit
Table 3. Frequency of Vb17a TCR1 Cells in Thymocyte Subpopulations
I-E2 Mouse Strain
Subpopulation SWR (H-2q) SJL (H-2s) C57L (H-2b)
CD3lo c-kit hi (DPint 1 CD81 progenitor) 2.2 6 0.1 2.5 6 0.9 2.7 6 0.6
CD4 lineage
CD3med c-kit hi (CD4hi CD8med) 8.7 6 2.5 8.5 6 1.9 4.6 6 1.3
CD3hi c-kit lo (CD4hi CD8lo) 12.6 6 1.8 11.9 6 1.6 5.8 6 0.4
CD3hi c-kit2 (CD4hi CD82) 14.1 6 1.7 11.2 6 2.3 4.2 6 0.7
CD8 lineage
CD3med c-kit hi (CD4med CD8hi) 3.8 6 0.8 5.0 6 0.9 3.3 6 0.3
CD3hi c-kit lo (CD4lo CD8hi) 4.3 6 1.1 7.3 6 1.1 5.8 6 0.6
CD3hi c-kit2 (CD42 CD8hi) 3.5 6 0.6 6.5 6 0.6 5.1 6 0.3
Analysis of CD4lo–med CD8hi and CD4hi CD8lo–med thymocyte populations were done by gating out CD4hi and CD8hi populations, respectively.
Data are shown as mean percent 6 SD (n 5 3).
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Figure 9. Size and Cell Cycle Status of Thymocytes on the c-kit1 Maturation Pathway
(A) FSC profiles and (B) cell cycle status of sorted thymocyte subsets on the c-kit1 maturation pathway. Cell cycle analysis was performed
by PI staining described in Experimental Procedures.
in the DPint subset, we ree¨xamined the CD4/CD8 gates data presented by Lucas et al. (1994) that the population
receiving positive selection (CD691) contained a highfrom our previous studies (Guidos et al., 1990), and con-
clude that the DPint c-kit1 cells would have been included percentage of cycling cells. At the transition from TCRmed
c-kit1 to TCRhi c-kit1 medium-sized cells, cell divisionin the DP blast cell fraction. It is likely that DPint cells
would also have been included in the DP population gradually turns off. These c-kit1 cells apparently down-
regulate c-kit and differentiate to SP thymocytes.defined in other studies. On the other hand, the true
DPhi (c-kit2) population is mostly composed of cells on Through all of these stages, high levels of Bcl-2 expres-
sion are preserved, which might contribute to their dura-the terminal stage of the default pathway; thevast major-
ity of the DPhi cells are destined to die, but also contain bility through the positive selection process (Linette et
al., 1994; Gratiot-Deans et al., 1994).progenitors with low frequency. We assume that this
differentiation from the DPhi cells is on a “salvage” path- In our recent data, the MHC class I/II–deficient mice
completely lack the c-kit1 maturation pathway repre-way. We present a model (Figure 11) that should be
used as a guide to the discussion. sented by TCRmed–hi c-kit1 cells, and have a lower (, 10%)
frequency of the TCRlo c-kithi population. The TCRmed–hiIt appears that the TCRlo c-kithi thymocytes produce
TCRmed c-kithi TIs as a result of positive selection by two c-kit1 population appears after an i.t. adoptive transfer
of its TCR2/lo c-kit1 thymocytes to normal (MHC class I/independent lines of evidence: first, the TCRlo c-kithi cells
are CD692, but their progeny TCRmed c-kithi transitional II–positive) hosts in 3–4 days (K. A. and I. L. W., unpub-
lished data). These data indicate that appropriate MHC–cells begin to express CD69, a surface molecule whose
expression reports TCR ligation; second, the relative TCR interactions are required for the emergence of the
c-kit1 maturation pathway, and suggest the possibilityincrease in Vb17a frequency in the TCRmed c-kithi popula-
tion over its immediate precursors, the DPint TCRlo c-kithi that some of the TCRlo c-kit1 thymocytes were in the
process of being (or had been) positively selected,blast cells, reflects theefficiency of Vb17a TCR selection
in mice with different I-A alleles. Accordingly, the TCRlo though most of them were negative for CD69. This partial
activation may be able to account for the rapid genera-c-kithi population might contain a significant fraction of
cells that are targets of positive selection. tion of SP cells from DPint c-kit1 cells on HTSCs. Alterna-
tively, DPint c-kit1 cells encounter environments in vivoPositive selection at the TCRlo (DPint) c-kit1 to TCRmed
c-kit1 stages could involve cell division, as they are that promote self-renewal rather than positive selection.
It is also possible that in vitro maturation enrichment ismainly in cell cycle (Figure 9). This is compatible with the
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Figure 10. Expression of Bcl-2 in Thymocytes on the c-kit1 Maturation Pathway
The expression of Bcl-2 in various thymocytes subsets. DP small thymocytes represent cells in elutriator fraction of 16–20 ml/min. Note that
cells on the c-kit1 maturation pathway are always positive for Bcl-2.
immediately accessible, while more complex cell sorting cells might contain thymocytes with an unsuccessful
(e.g., out of frame) TCR rearrangement or thymocytesmust occur in vivo before injected cells reach theirmatu-
ration microenvironment. with selectable TCRs that fail to encounter a “selectable
niche” (Huesmann et al., 1991; Merkenschlager et al.,Previous studies have shown that the the coexpres-
sion of CD4 and CD8 does not always require signaling 1994). The latter hypothesis is supported by the finding
that the DPint TCRlo c-kithi cells become DPhi (c-kit2) cellsby TCRab receptor (Levelt et al., 1993; Shinkai and Alt,
1994; Mombaerts et al., 1994; Guidos et al., 1995). In in the absence of stroma in vitro. The DPhi (TCRloc-kit2)
blasts that fail to receive positive selection continue toMHC class I/II–deficient mice, more than 90% of thymo-
cytes are DP cells (Crump et al., 1993), and are DPhi divide at least several times (Scollay and Godfrey, 1995).
It is possible that some fraction of the DPhi cells could beTCRlo–med c-kit2 thymocytes (K. A. and I. L. W., unpub-
lished data). These data imply that the DPhi (TCRlo c-kit2) salvaged by positive selection through the expression of
Figure 11. Model of Thymic Differentiation
c-kit and Bcl-2 are maintained in the thymic
developmental stages that are on the c-kit1
maturation pathway, while both molecules
are down-regulated in cells on the default
pathway. Some of the DPhi cells might still
maintain differentiation capacity on the c-kit2
salvage pathway. Curved arrows indicate cy-
cling cells.
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alternate TCRab receptors produced by secondary or in MHC class I– or class II–deficient mice are c-kit2
multiple TCRa rearrangements (Petrie et al., 1993; Alam (unpublished data). CD41CD8lo–med cells (Lundberg et al.,
et al., 1995), or through encountering the available se- 1995; Suzuki et al., 1995) have been reported to be an
lecting cells, or through both. The c-kit2 pathway might intermediate stage of differentiation from DPhi to CD81
be preferentially used in the CD4 lineage maturation, SP cells. Our results are in contrast with these reports
since most of the progeny of DPhi cells in vivo were CD4 in that c-kit1 CD4medCD81 and CD41CD8med TIs almost
SP cells. It is of interest whether the few cells on the exclusively differentiate into CD81 and CD41 SP cells,
c-kit2 pathway express Bcl-2 or Bcl-xL (Ma et al., 1995). respectively. In addition, the frequency of Vb17a1 thy-
The major progeny of DPint c-kit2 cells were DPhi cells, mocytes in CD3med–hi c-kit1 CD41CD8lo–med population in
suggesting that the majority of them were on the default SJL (H-2s) mice was slightly lower than that in SWR (H-
pathway, which terminates at the DPhi stage. The DPint 2q) mice, whereas the Vb17a frequency in CD3med–hi c-kit1
c-kit2 cells could also generate rare SP progeny on CD4lo–medCD81 populations in SJL mice was higher than
HTSCs (Figure 4). Among DPlo, DPint, and DPhi subfrac- that in SWR mice (Table 3), reflecting the efficiency of
tions, only the DPint (c-kit2) fraction contains cells that positive selection of Vb17a1 CD4 and CD8 SP cells,
express more than intermediate levels of TCR (Figure respectively. These data strongly suggest that the c-kit1
2). This population might correspond to the TCRhi DP CD41CD8lo–med stage is not the intermediate stage of CD8
cells, which are reportedly in transition to SP cells lineage maturation on the c-kit1 pathway. Accordingly,
(Shortman et al., 1991; Lucas et al., 1994); the TCRmed though we cannot conclusively compare the CD4/CD8
DPint c-kit2 cells contain CD691 cells (data not shown). profiles of the progenitors in those reports, it is possible
The source of the TCRmed DPint c-kit2 CD691 cells might that these CRS populations may belong to the c-kit2
include the DPhi cells, because the c-kit2 pathway from pathway, because the TCRlo c-kit2 cells also include
DPhi cells involves partial down-regulation of CD4 and considerable numbers of CD4medCD81 and CD41CD8med
CD8 coreceptors in vivo (Figure 7). However, the TCRmed TIs (Figure 3). In this case, theprogenitors for these c-kit2
DPint c-kit2 CD691 cells probably also include cells that CRS cells need to be identified in order to delineate
are receiving negative selection (Swat et al., 1991; Vas- seemingly asymmetrical developmental steps between
quez et al., 1992, 1994; Kersh and Hedrick, 1995), and CD4 and CD8 lineage commitment (Kydd et al., 1995;
those dying by default (Kishimoto et al., 1995). We can- Lundberg et al., 1995; Suzuki et al., 1995); in our hands,
not exclude the possibility that some TCRmed DPint c-kithi
the rare mature progeny from DPhi c-kit2 cells were
cells shut down c-kit expression immediately after re-
mainly CD4 SP cells.
ceiving positive selection, and sequentially mature from
The important issue is how significant the c-kit1 matu-
the TCRmed DPint c-kit2 stage to TCRhi c-kit2 SP cells. In
ration pathway is in vivo. We estimated that at least halfthat view, some fraction of TCRmed DPint c-kit2 progeni-
of SP mature thymocytes generated from this route.
tors may have derived from the DPint c-kit1 subset.
(The SP progeny of the c-kit1 pathway are based onThe developmental sequence of the c-kit1 maturation
robust frequency, while the estimation of rare eventspathway described here may not apply directly to TCR
from the c-kit2 pathway is an extrapolation.) At steady-transgenic mice; although the c-kit1 pathway repre-
state, z1–2 3 106 SP cells are replaced per day in youngsented by the TCRmed–hi c-kit1 cells was more evident in
adult mice, since the mature SP compartment(s) repre-female MHC class I–restricted H-Y TCR transgenic mice,
sented by TCRhi (mainly SP) cells gives rise to z 1–2 3the timing of CD4 and CD8 coreceptor regulation differs;
106 emigrants per day (Scollay et al., 1980). An estimatedtheTCRhi c-kit2 population contains a considerable num-
average residence time for the SP cells in the thymusber of DPhi cells in addition to CD8 SP cells (unpublished
is 14–17 days (Scollay and Godfrey, 1995), and this isdata). In these mice, theTCRab is expressed earlier than
in the range of what would be expected with a compart-in nontransgenic mice, as the result of the transgene
ment size of roughly 14–17 3 1 3 106 5 z1.4–1.7 3 107promotor/enhancer. This conceivably may play a part
SP cells. We found z1.5 3 107 cells in that compartmentin the earlier down-regulation of c-kit in these mice. A
(Figure 10). Because this compartment is mainly maderelative shortage of selecting stromal cells should also
up of nondividing cells, entry into the compartmentbe taken into account: the ratio of self-MHC–restricted
should almost equal cell loss from the compartment byTCR1 cells to selecting stromal cells would be massively
death or emigration. We found a minor fraction (z2%)increased in these transgenic mice (van Ewijik et al.,
of this compartment was at the S/G2/M stage of the cell1990; Huesmann et al.,1991). In thesemice, it is reported
cycle (Figure 10). These cycling SP cells at least partlythat small TCRlo DP cells can differentiate to CD8 SP
contribute to the expansion of TCRhi c-kit2 (SP) cells ascells (Lundberg and Shortman, 1994; Swat et al., 1994).
previously reported (Egerton et al., 1990; Lucas et al.,The majority of transgenic DP cells are medium sized,
1994; Scollay and Godfrey, 1995).and are TCRmedc-kit2 by our definition (K. A. and I. L. W.,
On the c-kit1 pathway, the majority of TCRlo c-kithiunpublished data). It is possible that cells in the c-kit2
(DPint) cells (area 2: z4 3 105 cells in the thymus) andpathway are amplified in these TCR transgenic mice.
the TCRmed c-kithi cells (area 3 plus area 4: z4 3 105These experiments do not solve the question of
cells) are cycling (Figure 10). Some fraction of TCRhiwhether the DPint c-kit1 thymocytes may be “instructed”
c-kitlo cells is also in cell cycle, because z5% (z1.5 3to down-regulate the unused coreceptor (Borgulya et
105 cells) of them are at the S/G2/M stage (Figure 10).al., 1991; Robey et al., 1991), or whether the CRS cells
The accurate residence time and cell cycle time in eacharise stochastically, but only cells with matched TCR/
compartment is not yet known, though the average resi-coreceptor are then selected (Chan et al., 1993; Crump
dence time in these intermediate compartments (areaset al., 1993; van Meerwijk and Germain, 1993; van Meer-
wijk et al., 1995). In our hands, these CRS populations 3–5) is z4 days in our in vivo experiments. The average
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H1.2F3 (anti-CD69), and H57–579 (anti-TCRb were purchased fromcell cycle time in the thymus has been reported to be
PharMingen (San Diego, California). They were visualized with avi-z6–8 hr (Metcalf and Wiadrowski, 1966). Accordingly,
din–Texas red or avidin–PE(Becton Dickinson, San Jose, California).it is reasonable to postulate that precursors on the c-kit1
pathway produce a considerable part of 1–2 3 106 TCRhi Size Fractionation of Thymocytes by Centrifugal Elutriation
c-kit2 (SP) progeny per day. Single-cell suspensions of thymocytes were obtained from thymus
In the present study, we have been unable to demon- from five mice (4 weeks old) by passing through a stainless mesh
followed by a 70 mm nylon cell strainer (Falcon 2350; Becton Dickin-strate a clear function for c-kit in the maturation of the
son Labware, Franklin Lakes, New Jersey). They were resuspendedthymocytes, as Slf alone did not replace stroma to en-
at 1 3 108 cells/ml in phosphate-buffered saline containing 0.5%able maturation along either SP lineage, and neutralizing
bovine serum albumin (PBS/BSA). We loaded 10 ml of these cells
antibodies to c-kit and Slf in the presence of stroma did into an J2-21M elutriator with a JE6B rotor (Beckman Instruments,
not prevent full maturation along both SP lineages. It is Palo Alto, California) spinning at 3000 rpm at 48C. The cells were
probable that since c-kit expression is rapidly down- elutriated with continuous flow of PBS/BSA into 200 ml fractions.
The loading flow-through fraction was collected at 16 ml/min, andregulated after acquisition of high levels of TCR, Slf–c-
contained erythrocytes and dead cells. We divided thymocytes intokit interaction might only be required for proliferation
four fractions such as 16–20 ml/min, 21–24 ml/min, 25–28ml/min,(Rodewalt et al., 1995) at or immediately before the TCRlo
and rotor-off populations.
c-kithi stage, but not for differentiation. The thymocytes
on the c-kit1 pathway maintain expression of IL-7 recep- Cell Sorting and Flow Cytometric Analysis
tor (unpublished data). Accordingly, it is necessary to Freshly isolated thymocytes or blast thymocytes obtained by elutria-
tion described above were stained for multicolor analysis, and thedetermine possible roles of other cytokines such as IL-7
fluorescence was analyzed using a highly modified dual (488 nmand flk-2 ligand (Lyman et al., 1993; von Freeden-Jeffry
argon laser and 599 nm dye laser) or triple laser (plus 390 nm argonet al., 1995) on the proliferation, differentiation, or both,
laser) FACS (Becton Dickinson Immunocytometry Systems, Moun-of c-kit1 precursors.
tain View, California) with four-decade logarithmic amplifiers as de-
We should emphasize that in this report we have not scribed (Parks andHerzenberg, 1984). B cells, monocytes, and gran-
investigated nor have we clarified maturation pathways ulocytes appeared as a minority in the 21–28 ml/min elutriator
fraction and were virtually depleted in the rotor-off (blast) populationbeginning with the earliest defined precursor class
as detected by five-color staining with biotinylated B-220, Mac-1,(TCR2CD4loCD82) of thymocytes (Wu et al., 1991). It is
and Gr-1, followed by avidin–Texas red in addition to CD4–PE, CD8–reasonable to assume that this population might be in-
FITC, c-kit–APC, and propidium iodide (PI) by using triple-laser
cluded in the DPlo c-kitlo–hi (TCR2) fraction. FACS. This minor population of other lineages (<0.01% of freshly
In summary, we have investigated the progenitor ac- isolated thymocytes) were c-kit2. Accordingly, most data presented
tivity of DP thymocytes, subdividing them into the DPint in this paper were on four-color analysis by a dual-laser FACS. DP
populations obtained by the first round sort using strict FLS gatesand DPhi subsets. We have shown that at least a half of
still contained <1% of TIs as well as SP cells, probably due tothymocytes on the maturation pathway preserve ex-
doublets in the samples or coincidental sorting of wrong dropletspression of c-kit and Bcl-2, and differentiate through
adjacent to target droplets. We subjected the sorted cells to a sec-DPint TCRlo c-kit1 progenitors, not through DPhi TCRlo
ond round of FACS sorting, and the highly purified populations were
c-kit2 cells. A significant fraction of the DPint c-kit1 cells used for experiments (Figure 5). Dead cells were detected by adding
initiates and completes maturation to SP T cells on 1 mg/ml of PI, and gated out by setting an electronic gate to exclude
PI1 cells. Fluorescence data were analyzed by FACS/DESK program,HTSCs within 1 day, opening the way to a reductionist
and presented either in the form of histograms or two-parameterapproach toparticular lymphostromal interactions. Pos-
probability plots (5%).itive selection operates on the DPint TCRlo c-kit1 cells to
generate TIs. The presence of the two distinct matura-
FACS Analysis for Bcl-2
tion pathways warrants the ree¨valuation of various mod- The staining of Bcl-2 has been done according to the modified
els of lineage commitment. method by Veis et al. (1993). After surface staining, the cells were
fixed with 2% paraformaldehyde for 5 min at 48C. The cells were
washed and treated with 0.3% saponin for 10 min in room tempera-Experimental Procedures
ture. After this fixation procedure, the cells werestained with purified
hamster anti-mouse Bcl-2 antibody (PharMingen), followed by PEMice
or FITC-conjugated goat anti-hamster IgG (Caltag Laboratories, SanC57BL/6/Ka (Ly5.1; Thy1.2), C57BL/6. Ly5.2 (Ly5.2; Thy1.2), and
Francisco, California), using a staining media of PBS containingC57BL/Ka. Thy1.1 (Ly5.1; Thy1.1) 4-week-old mice were bred and
0.03% saponin. They were analyzed by a dual-laser FACS.maintained in the central animal facility in the Department of Com-
parative Medicine, Stanford University. C57L, SWR, and CBA/J mice
were purchased from the Jackson Laboratory (Bar Harbor, Maine). Cell Cycle Analysis
The FACS sorted cells (usually 5 3 104 cells) were suspended with
500 ml of distilled water containing 0.1% of Triton-X 100, 50 mg/mlAntibodies
of PI, and 0.1% of sodium citrate. After overnight on ice, they wereThe antibodies used in immunofluorescence staining included
analyzed by a dual-laser FACS.19XE5 (anti-Thy1.1); AL1-4A2 (anti-Ly5.1); 2B8 (anti-c-kit, CD117)
(Ikuta and Weissman, 1992); KT-31 (anti-CD3); GK-1.5 (anti-CD4);
53-6.7 (anti-CD8); 6B2 (anti-B220), M1/70 (anti-Mac-1), and 8C5 HTSC Culture System
Thymic stroma cells from 4- to 6-week-old C57BL/6/Ka or C57BL/(anti-Gr-1). Mouse and hamster antibodies (e.g., 19XE5) were puri-
fied by protein A affinity chromatography, and rat antibodies (e.g., Ka. Thy1.1 mice were cultured as described previously in detail
(Small et al., 1984, 1989; Sen-Majumdar et al., 1992). In brief, after6B2, M1/70) were purified by protein G affinity chromatography.
GK-1.5 and 53-6.7 were always conjugated with phycoerythrin (PE) releasing most thymocytes, passing through the stainless steel
mesh, stromal cells were grown in MEM containing D-valine for 2–3(Cyanotech Corporation, Kailua-Kona, Hawaii) and fluorescein-5-
isothiocyanate (FITC) (Molecular Probes, Incorporated, Eugene, Or- weeks. Then, the adherent cells from primary culture dishes were
removed by trypsin–EDTA treatment, and placed into 96-wellegon), respectively. 2B8 and AL1-4A2 were conjugated with allophy-
cocyanin (APC) (Cyanotech Corporation). The other antibodies were (Costar, Cambridge, Massachusetts) plates. D-valine containing
medium was withdrawn just before sorted thymocytes were addedbiotinylated. Biotinylated GL3 (anti-TCRgd), FITC-conjugated
c-kit1 Thymic Maturation Pathway
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to the epithelial cultures. Sorted thymocytes (usually 2–4 3 104 cells) Brandle, D., Muller, S., Muller, C., Hengartner, H., and Pircher, H.
(1994). Regulation of RAG1 and CD69 expression in the thymuswere resuspended in RPMI-1640 supplemented with 10% fetal calf
serum, L-glutamine, and penicillin–streptomycin. After the culture, during positive and negative selection. Eur. J. Immunol. 24, 145–151.
thymocytes were removed by gentle pipetting. The harvested cells Chan, S.H., Cosgrove, D., Waltzinger, C., Benoist, C., and Mathis,
were stained with CD4–PE, CD8–FITC, PI, biotinylated CD3, or some D. (1993). Another view of the selection model of thymic selection.
combination, followed by avidin–Texas red. Contamination of stro- Cell 73, 225–236.
mal cells and dead cells was avoided by setting a strict electronic
Crispe, I.N., Moore, M.W., Husmann, L.A., Smith, L., Bevan, M.J.,
gate of forward angle light scatter and obtuse scatter and by PI
and Shimonkevitz, R.P. (1987). Differentiation potential of subsets
staining. Polyclonal rabbit neutralizing anti-mouse Slf, and mono-
of CD42CD82 thymocytes. Nature 329, 336–339.
clonal rat neutralizing anti-mouse c-kit (ACK-2) (Nishikawa et al.,
Crump, A.L., Grusby, M.J., Glimcher, L.H., and Cantor, H. (1993).1991) were purchased from Genzyme (Cambridge, Massachusetts),
Thymocyte development in major histocompatibility complex–and GIBCO BRL (Gaithersburg, Maryland), respectively. Titration of
deficient mice: evidence for stochastic commitment to the CD4 andthese antibodies was done by using a murine Slf- and IL-7-depen-
CD8 lineages. Proc. Natl. Acad. Sci. USA 90, 10739–10743.dent cell line (Domen etal., 1993). Of the former, 1 mg could neutralize
Domen, J., van der Lugt, N.M.T., Acton, D., Laird, P.W., Linders, K.,1 ng/ml of recombinant rat Slf. In inhibition analyses, stromal cells
and Berns, A. (1993). Pim-1 levels determine the size of early Bwere incubated with 500 ml of RPMI-1640 containing 10% fetal calf
lymphoid compartments in bone marrow. J. Exp. Med. 178, 1665–serum and 1 mg of anti-mouse Slf, and FACS-sorted c-kit1 thymo-
1673.cytes were incubated with 500 ml of RPMI-1640 containing 10%
fetal calf serum and 1 mg/ml of ACK-2 for 30 min before the start Egerton, M., Scollay, R., and Shortman, K. (1990). Kinetics of mature
of cultures. Recombinant rat Slf (provided by Amgen, Incorporated) T-cell development in the thymus. Proc. Natl. Acad. Sci. USA 87,
was used at 1 ng/ml. 2579–2582.
Fowlkes, B.J., and Schweighoffer, E. (1995). Positive selection of T
Intrathymic Injection cells. Curr. Opin. Immunol. 7 188–195.
The details of the surgical procedure have been described else-
Godfrey, D.I., Zlotnik, A., and Suda, T. (1992). Phenotypic and func-where (Guidos et al., 1989, 1990). Blast thymocytes isolated from
tional characterization of c-kit expression during intrathymic T cellC57BL/Ka. Thy1.1 (Ly 5.1; Thy1.1) mice by CCE and cell sorting in
development. J. Immunol. 149, 2281–2285.10 ml of saline were injected into a thymic lobe of anesthetized
Gratiot-Deans, J., Ding, L., Turka, L.A., and Nunez, G. (1993). bcl-2unirradiated 3- to 5-week-old C57BL/6. Ly5.2 (Ly 5.2; Thy1.2) mice.
proto-oncogene expression during human T cell development: evi-In most instances, we injected 1–2 3 106 and z1 3 105 of double-
dence for biphasic regulation. J. Immunol. 151, 83–91.sorted DPhi and DPint c-kithi cells, respectively. Thymocyte suspen-
sions made from individual thymic lobes were stained with biotinyl- Gratiot-Deans, J., Merino, R., Nunez, G., and Turka, L.A. (1994).
ated anti-Thy 1.2 antibodies 3 or 4 days later. Cells were washed and Bcl-2 expression during T-cell development: early loss and late re-
resuspended in 1 ml staining medium plus 200 ml avidin-conjugated turn occur at specific stages of commitment to differentiation and
paramagnetic beads (Advanced Magnetics, Incorporated, Cam- survival. Proc. Natl. Acad. Sci. USA 91, 10685–10689.
bridge, Massachusetts). After 30 min at 48C with constant mixing, Guidos, C.J., Weissman, I.L., and Adkins, B. (1989). Developmental
cell–bead complexes were removed from free cells using a magnetic potential of CD4282 thymocytes: peripheral progeny include mature
separator (BioMag; Advanced Magnetics, Incorporated, Cambridge, CD4282 T cells bearing ab T cell receptor. J. Immunol. 142, 3773–
Massachusetts). The free cells were stained with avidin–Texas red, 3780.
PE–GK1.5or KT31.1, APC–56.6.8 or 2B8,and FITC–Ly 5.1. The donor
Guidos, C.J., Danska, J.S., Fathman, C.G., and Weissman, I.L.cellswere seen as theTexas red–negative, FITC-positive population.
(1990). T cell receptor–mediated negative selection of autoreactiveAll data of donor cells was collected by setting electronic gates.
T lymphocyte precursors occurs after commitment to the CD4 or
CD8 lineages. J. Exp. Med. 172, 835–845.
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